Complementary Medicine Not Tied to Prostate Cancer Outcome
Complementary, alternative medicine widely used in prostate cancer but it shows no effect on treatment satisfaction, outcomes.
Endocrine Cancer
Ethnicity, Sexual Preference Impact Post-treatment Quality of Life in Prostate Cancer Patients
In this paper, the authors reviewed evidence of the impact of confounding factors, such as ethnicity and sexual preference, on quality of life parameters in patients with prostate cancer.
Low-Dose Radioiodine Effective in Low-Risk Thyroid Cancer
Between 1973 and 2002, the incidence of thyroid cancer has nearly tripled in the US, from 2.7 to 7.7 cases per 100,000, with similar increases reported in Europe.
Chemo Combo May Benefit Adrenocortical Cancer
Therapy has higher antitumor efficacy as first- and second-line therapy vs. streptozocin-mitotane
Percutaneous Irreversible Electroporation Ablates Pancreatic Tumors
Percutaneous irreversible electroporation (IRE) is feasible and safe in patients with locally advanced pancreatic adenocarcinoma, with 2 of 8 patients with unresectable disease achieving a margin-negative resection.
Radiopeptide Combination Improves Survival in Metastatic Neuroendocrine Cancers
Patients with metastasized neuroendocrine cancers had improved efficacy and overall survival following repeated cycles of two of the most commonly used radioisotopes in somatostatin-based radiopeptide therapy.
Drug Ups Effect of Gemcitabine in Pancreatic Cancer
The efficacy of gemcitabine in treating pancreatic cancer can be greatly improved by a second drug that increases gemcitabine levels by preventing its breakdown, according to a study published online February 28 in Cancer Discovery.
Dual VEGF and c-MET Inhibition Synergistically Reduces Tumor Invasion and Metastasis
Simultaneous inhibition of c-Met and VEGF signaling slowed tumor growth and reduced invasion and metastasis in a pancreatic neuroendocrine mouse model, results of a study published online in Cancer Discovery February 24 have found.
Family History Ups Risk of Differentiated Thyroid Cancer
Family history of thyroid cancer in a first-degree relative may be associated with an increased risk of sporadic differentiated thyroid carcinoma (DTC), according to a study published in the March 1 issue of Cancer.
Drug Screening Finds Existing Agents with Potential Activity Against Thyroid Cancer
Researchers have increasingly begun to evaluate existing approved drugs for other clinical uses in an effort to circumvent the extensive process of drug discovery and development.
- Loading...
Loading...
Next post in Endocrine Cancer
Loading... 
Loading...